| Original language | English (US) |
|---|---|
| Pages (from-to) | 2372-2375 |
| Number of pages | 4 |
| Journal | Journal of the American College of Cardiology |
| Volume | 75 |
| Issue number | 18 |
| DOIs | |
| State | Published - May 12 2020 |
Keywords
- NSTEMI
- STEMI
- catheterization laboratory
- coronavirus
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic : From the ACC's Interventional Council and SCAI. / American College of Cardiology's Interventional Council and the Society for Cardiovascular Angiography and Interventions.
In: Journal of the American College of Cardiology, Vol. 75, No. 18, 12.05.2020, p. 2372-2375.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic
T2 - From the ACC's Interventional Council and SCAI
AU - American College of Cardiology's Interventional Council and the Society for Cardiovascular Angiography and Interventions
AU - Welt, Frederick G.P.
AU - Shah, Pinak B.
AU - Aronow, Herbert D.
AU - Bortnick, Anna E.
AU - Henry, Timothy D.
AU - Sherwood, Matthew W.
AU - Young, Michael N.
AU - Davidson, Laura J.
AU - Kadavath, Sabeeda
AU - Mahmud, Ehtisham
AU - Kirtane, Ajay J.
N1 - Funding Information: Dr. Welt has served as a site principal investigator for a multicenter trial supported by Medtronic; and has received compensation from Medtronic for participating on an Advisory Board. Dr. Shah has received compensation as a proctor for Edwards Lifesciences; and has received educational grants from Edwards, Medtronic, and Abbott; and Dr. Shah's wife is an employee of ThermoFisher Scientific. Dr. Aronow has a financial relationship with Silk Road Medical. Dr. Sherwood has received consulting fees from Medtronic. Dr. Mahmud has received consulting fees from Abiomed, Medtronic, and Boston Scientific; has an equity interest in Abiomed; is the national principal investigator for the Precision GRX study by Corindus; and is a site principal investigator for multicenter trials supported by CSI and Abbot Vascular. Dr. Bortnick has served as a site principal investigator for multicenter trials sponsored by Abbott, AstraZeneca, Sanofi, and CSL-Behring, for which her institution received compensation; has received an honorarium from ClearView Healthcare Partners; and has received support from an American Heart Association Mentored and Clinical Population Research Award (17MCPRP33630098) and National Heart, Lung, and Blood Institute grant 1K23HL146982-01A1. Dr. Kirtane has received Institutional funding to Columbia University and/or Cardiovascular Research Foundation from Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, Philips, and ReCor Medical (personal: CME/conference honoraria and travel/meals only). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Funding Information: Dr. Welt has served as a site principal investigator for a multicenter trial supported by Medtronic; and has received compensation from Medtronic for participating on an Advisory Board. Dr. Shah has received compensation as a proctor for Edwards Lifesciences; and has received educational grants from Edwards, Medtronic, and Abbott; and Dr. Shah’s wife is an employee of ThermoFisher Scientific. Dr. Aronow has a financial relationship with Silk Road Medical. Dr. Sherwood has received consulting fees from Medtronic. Dr. Mahmud has received consulting fees from Abiomed, Medtronic, and Boston Scientific; has an equity interest in Abiomed; is the national principal investigator for the Precision GRX study by Corindus; and is a site principal investigator for multicenter trials supported by CSI and Abbot Vascular. Dr. Bortnick has served as a site principal investigator for multicenter trials sponsored by Abbott, AstraZeneca, Sanofi, and CSL-Behring, for which her institution received compensation; has received an honorarium from ClearView Healthcare Partners; and has received support from an American Heart Association Mentored and Clinical Population Research Award (17MCPRP33630098) and National Heart, Lung, and Blood Institute grant 1K23HL146982-01A1. Dr. Kirtane has received Institutional funding to Columbia University and/or Cardiovascular Research Foundation from Medtronic, Boston Scientific, Abbott Vascular, Abiomed, CSI, Philips, and ReCor Medical (personal: CME/conference honoraria and travel/meals only). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2020/5/12
Y1 - 2020/5/12
KW - NSTEMI
KW - STEMI
KW - catheterization laboratory
KW - coronavirus
UR - http://www.scopus.com/inward/record.url?scp=85083264691&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083264691&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2020.03.021
DO - 10.1016/j.jacc.2020.03.021
M3 - Article
C2 - 32199938
AN - SCOPUS:85083264691
SN - 0735-1097
VL - 75
SP - 2372
EP - 2375
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 18
ER -